Medipal Holdings Stock Fundamentals
| MEPDF Stock | USD 16.50 0.00 0.00% |
Fundamental analysis of MediPal Holdings allows traders to better anticipate movements in MediPal Holdings' stock price by examining its financial health and performance throughout various phases of its business cycle.
MediPal |
MediPal Holdings Company Return On Asset Analysis
MediPal Holdings' Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current MediPal Holdings Return On Asset | 0.0169 |
Most of MediPal Holdings' fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, MediPal Holdings is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
| Competition |
Based on the latest financial disclosure, MediPal Holdings has a Return On Asset of 0.0169. This is 100.19% lower than that of the Healthcare sector and 99.42% lower than that of the Medical Distribution industry. The return on asset for all United States stocks is 112.07% lower than that of the firm.
MediPal Holdings Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining MediPal Holdings's current stock value. Our valuation model uses many indicators to compare MediPal Holdings value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across MediPal Holdings competition to find correlations between indicators driving MediPal Holdings's intrinsic value. More Info.MediPal Holdings is regarded third in return on equity category among its peers. It is considered to be number one stock in return on asset category among its peers reporting about 0.30 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for MediPal Holdings is roughly 3.32 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the MediPal Holdings' earnings, one of the primary drivers of an investment's value.MediPal Return On Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses MediPal Holdings' direct or indirect competition against its Return On Asset to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of MediPal Holdings could also be used in its relative valuation, which is a method of valuing MediPal Holdings by comparing valuation metrics of similar companies.MediPal Holdings is currently under evaluation in return on asset category among its peers.
MediPal Fundamentals
| Return On Equity | 0.0561 | |||
| Return On Asset | 0.0169 | |||
| Profit Margin | 0.01 % | |||
| Operating Margin | 0.01 % | |||
| Current Valuation | 1.24 B | |||
| Shares Outstanding | 209.96 M | |||
| Shares Owned By Insiders | 9.02 % | |||
| Shares Owned By Institutions | 27.34 % | |||
| Price To Earning | 15.57 X | |||
| Price To Book | 0.76 X | |||
| Price To Sales | 0.0008 X | |||
| Revenue | 3.29 T | |||
| Gross Profit | 217.44 B | |||
| EBITDA | 71.64 B | |||
| Net Income | 29.42 B | |||
| Cash And Equivalents | 237.6 B | |||
| Debt To Equity | 0.04 % | |||
| Current Ratio | 1.21 X | |||
| Book Value Per Share | 2,629 X | |||
| Cash Flow From Operations | 61.22 B | |||
| Earnings Per Share | 0.95 X | |||
| Number Of Employees | 12.8 K | |||
| Beta | 0.26 | |||
| Market Capitalization | 2.79 B | |||
| Total Asset | 1.71 T | |||
| Z Score | 1.0 | |||
| Annual Yield | 0.03 % | |||
| Net Asset | 1.71 T | |||
| Last Dividend Paid | 46.0 |
About MediPal Holdings Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze MediPal Holdings's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of MediPal Holdings using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of MediPal Holdings based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Medipal Holdings Corporation engages in the prescription pharmaceutical wholesale business in Japan. Medipal Holdings Corporation was founded in 1898 and is headquartered in Tokyo, Japan. MEDIPAL HOLDINGS operates under Medical Distribution classification in the United States and is traded on OTC Exchange. It employs 12801 people.
Currently Active Assets on Macroaxis
| DD | Dupont De Nemours | |
| CRDO | Credo Technology Group | |
| GOOG | Alphabet Inc Class C | |
| BAC | Bank of America | |
| CRM | Salesforce |
Other Information on Investing in MediPal Pink Sheet
MediPal Holdings financial ratios help investors to determine whether MediPal Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in MediPal with respect to the benefits of owning MediPal Holdings security.